[go: up one dir, main page]

FI970009A - Immunomodulaattoreita - Google Patents

Immunomodulaattoreita Download PDF

Info

Publication number
FI970009A
FI970009A FI970009A FI970009A FI970009A FI 970009 A FI970009 A FI 970009A FI 970009 A FI970009 A FI 970009A FI 970009 A FI970009 A FI 970009A FI 970009 A FI970009 A FI 970009A
Authority
FI
Finland
Prior art keywords
immunomodulators
Prior art date
Application number
FI970009A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970009A0 (fi
Inventor
Larsen Christian Groenhoej
Borbala Gesser
Original Assignee
Steeno Res Group As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steeno Res Group As filed Critical Steeno Res Group As
Publication of FI970009A0 publication Critical patent/FI970009A0/fi
Publication of FI970009A publication Critical patent/FI970009A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI970009A 1994-07-05 1997-01-02 Immunomodulaattoreita FI970009A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK80094 1994-07-05
PCT/DK1995/000227 WO1996001318A1 (en) 1994-07-05 1995-06-07 Immunomodulators

Publications (2)

Publication Number Publication Date
FI970009A0 FI970009A0 (fi) 1997-01-02
FI970009A true FI970009A (fi) 1997-03-04

Family

ID=8097707

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970009A FI970009A (fi) 1994-07-05 1997-01-02 Immunomodulaattoreita

Country Status (28)

Country Link
US (3) US6159937A (zh)
EP (2) EP0769054B1 (zh)
JP (1) JPH10502249A (zh)
CN (1) CN1216992C (zh)
AP (1) AP690A (zh)
AT (1) ATE195003T1 (zh)
AU (1) AU686816B2 (zh)
BR (1) BR9508243A (zh)
CA (1) CA2194444C (zh)
CZ (1) CZ1497A3 (zh)
DE (1) DE69518156T2 (zh)
DK (1) DK0769054T3 (zh)
EE (1) EE03451B1 (zh)
ES (1) ES2148525T3 (zh)
FI (1) FI970009A (zh)
GR (1) GR3034628T3 (zh)
HK (1) HK1012416A1 (zh)
HU (1) HU220344B (zh)
MX (1) MX9606537A (zh)
NO (1) NO970020L (zh)
NZ (1) NZ287406A (zh)
PL (1) PL181042B1 (zh)
PT (1) PT769054E (zh)
RO (1) RO118758B1 (zh)
RU (1) RU2218348C2 (zh)
SK (1) SK283096B6 (zh)
UA (1) UA57702C2 (zh)
WO (1) WO1996001318A1 (zh)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
WO1997040849A1 (en) * 1996-05-02 1997-11-06 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6086868A (en) * 1997-04-30 2000-07-11 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
AU9449398A (en) * 1997-10-10 1999-05-03 Imperial College Innovations Ltd. Use of csaidtm compounds for the management of uterine contractions
WO2000037096A2 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
ES2235889T3 (es) * 1999-05-25 2005-07-16 Canji, Inc. Terapia genica de la enfermedad pulmonar.
WO2002045737A2 (en) * 2000-12-07 2002-06-13 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
US20040086896A1 (en) * 2001-04-19 2004-05-06 Julie Carman Polynucleotides and polypeptides associated with the NF-kB pathway
EP1487465A4 (en) * 2002-02-11 2007-05-30 Arkion Life Sciences Llc CLEANED CYTOKIN-INHIBITING FACTOR
EP1490101A4 (en) * 2002-03-05 2006-09-20 Univ Texas METHODS OF IMPROVING INDUCTION OF IMMUNE RESPONSE INVOLVING MDA-7
EP1444989A1 (en) * 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
WO2004103294A2 (en) * 2003-05-15 2004-12-02 Tanox, Inc. Methods and compositions for the prevention and treatment of sepsis
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
US20050164244A1 (en) * 2003-10-23 2005-07-28 David Glass Methods of determining juvenile arthritis classification
US8034790B2 (en) * 2003-12-01 2011-10-11 Introgen Therapeutics Use of MDA-7 to inhibit pathogenic infectious organisms
US8034773B2 (en) * 2004-02-05 2011-10-11 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
US8178649B2 (en) * 2004-12-07 2012-05-15 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
AU2006211960A1 (en) * 2005-02-08 2006-08-17 Board Of Regents, The University Of Texas System Compositions and methods involving MDA-7 for the treatment of cancer
US20100028296A1 (en) * 2005-05-02 2010-02-04 Chavez Raymond A Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
WO2006130581A2 (en) 2005-05-31 2006-12-07 Avigen, Inc. Methods for delivering genes
US20090324616A1 (en) * 2006-06-21 2009-12-31 Giorgio Stassi Differential cytokine expression in human cancer
CA2656135A1 (en) * 2006-07-06 2008-01-10 Apogenix Gmbh Human il-4 muteins in cancer therapy
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
US8460697B2 (en) * 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
CN101391103B (zh) * 2008-07-31 2013-07-24 张可 一种预防和治疗艾滋病病毒感染的药物组合物
WO2010022227A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Methods for monitoring il-10 therapy
WO2011047097A2 (en) 2009-10-13 2011-04-21 Sigalov Alexander B Inhibition of trem receptor signaling with peptide variants
CN103476933B (zh) * 2011-03-14 2016-04-13 弗洛格有限公司 白介素1受体的拮抗剂
SMT202000321T1 (it) 2012-02-13 2020-07-08 Agency Science Tech & Res ANTICORPI MONOCLONALI UMANI CHE NEUTRALIZZANO IL-β
EP3021873B8 (en) 2013-07-18 2018-10-24 Xalud Therapeutics, Inc. Composition for the treatment of inflammatory joint disease
JP6140566B2 (ja) * 2013-07-31 2017-05-31 アイシン・エィ・ダブリュ株式会社 コイル装着方法及びコイル装着治具
CN105944086B (zh) * 2016-06-13 2017-08-25 浙江生创精准医疗科技有限公司 Il‑8单独或与其他细胞因子联合在治疗肝纤维化中的用途
EP3551034A1 (en) 2016-12-07 2019-10-16 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
US11596670B2 (en) 2017-03-30 2023-03-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist
US20220249814A1 (en) 2018-11-19 2022-08-11 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
EP3919906B1 (en) * 2019-01-31 2025-01-01 Sekisui Medical Co., Ltd. Method for immunologically analyzing free aim in biological specimen, and method for detecting nash in subject
CN115666704A (zh) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
AU678137B2 (en) * 1991-08-06 1997-05-22 Schering Corporation Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
JPH07504437A (ja) * 1992-03-04 1995-05-18 シェリング・コーポレーション 対宿主性移植片病を抑制するインターロイキン−１０の使用
CA2085291A1 (en) * 1992-07-30 1994-01-31 Martin L. Breitman Novel receptor tyrosine kinase
HU220103B (hu) * 1992-08-20 2001-10-28 Schering-Plough Corp. IL-10 új alkalmazása
SK8396A3 (en) * 1993-07-26 1997-03-05 Schering Corp Antagonists and agonists of human interleukin-10

Also Published As

Publication number Publication date
JPH10502249A (ja) 1998-03-03
PL319429A1 (en) 1997-08-04
PT769054E (pt) 2000-11-30
NZ287406A (en) 1998-07-28
EP0769054B1 (en) 2000-07-26
ATE195003T1 (de) 2000-08-15
AP9700962A0 (en) 1997-04-30
NO970020L (no) 1997-03-05
HUT76673A (en) 1997-10-28
EP0769054A1 (en) 1997-04-23
WO1996001318A1 (en) 1996-01-18
EE9700029A (et) 1997-08-15
SK161496A3 (en) 1997-08-06
AU686816B2 (en) 1998-02-12
MX9606537A (es) 1997-12-31
CA2194444C (en) 2003-01-14
PL181042B1 (pl) 2001-05-31
CN1216992C (zh) 2005-08-31
GR3034628T3 (en) 2001-01-31
ES2148525T3 (es) 2000-10-16
DE69518156D1 (de) 2000-08-31
US6159937A (en) 2000-12-12
CA2194444A1 (en) 1996-01-18
BR9508243A (pt) 1997-10-21
RU2218348C2 (ru) 2003-12-10
AU2612195A (en) 1996-01-25
DK0769054T3 (da) 2000-11-13
EP1013764A1 (en) 2000-06-28
DE69518156T2 (de) 2001-01-11
CZ1497A3 (en) 1997-05-14
FI970009A0 (fi) 1997-01-02
SK283096B6 (sk) 2003-02-04
AP690A (en) 1998-10-16
US6599501B1 (en) 2003-07-29
NO970020D0 (no) 1997-01-03
HK1012416A1 (en) 1999-07-30
HU220344B (hu) 2001-12-28
RO118758B1 (ro) 2003-10-30
CN1159830A (zh) 1997-09-17
EE03451B1 (et) 2001-06-15
US6168791B1 (en) 2001-01-02
UA57702C2 (uk) 2003-07-15
HU9603615D0 (en) 1997-02-28

Similar Documents

Publication Publication Date Title
DK0769054T3 (da) Immunmodulatorer
ATA166795A (de) Bis-resorcinyltriazine
ATA147195A (de) Alkoxyphenyl-substituierte bisbenzoylphosphinoxide
ATA163695A (de) 2-hydroxyphenyltriazine
BR9507091A (pt) Combinações insecticidamente ativas
ATA108995A (de) Differenzdruckakkumulator
ATA11894A (de) Stauförderbahn
BR7400683U (pt) Odontoportátil
ATE197372T1 (de) Vorteig
BR7400635U (pt) Entopstop
BR7402342U (pt) Hidro-potenciômetro
BR7400062U (pt) Prato-bandeja
BR7400170U (pt) Mouráo
BR7400242U (pt) Tele-comando
BR7400030U (pt) Numeralfa
ATA127394A (de) Holografischer neurochip
BR7400865U (pt) Multi-arremate
BR7400879U (pt) Boxboy
BR7401141U (pt) PortA-espoNja
BR7401146U (pt) Translixo
BR7401734U (pt) Termometro-caneta
BR7401742U (pt) Sub-capacete
BR7401967U (pt) Vassoura-mangueira
BR7402083U (pt) Chuveiro-balde
BR7400053U (pt) T-compacto

Legal Events

Date Code Title Description
MA Patent expired